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Abstract: Vitamin D and calcium insufficiencies are risk factors for multiple chronic 
diseases. Data from 46 recent studies from Europe, North America, South-East Asia and 
the South Pacific area clearly indicate that a low vitamin D status and inadequate calcium 
nutrition are highly prevalent in the general population (30–80%), affecting both genders. 
The extent of insufficiencies is particularly high in older populations, and in some 
geographical areas, also in children and in young women of child-bearing age, in ethnic 
minorities and immigrants, as well as in people of low socio-economic status. Enrichment 
of cereal grain products with vitamin D and calcium would be a viable approach to 
increase consumption and improve health outcomes in the general population worldwide. 
Keywords: vitamin D status; calcium intake; 25-hydroxyvitamin D; 1,25-dihydroxy-
vitamin D; calcium-sensing receptor; osteoporosis; colorectal cancer; breast cancer; 
prevention; food fortification  
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1. Introduction 
It is common knowledge that an inadequate supply of vitamin D and calcium has negative effects 
on bone health at all ages, inasmuch as it causes rickets in infants, retards acquisition of an adequate 
bone mass during skeletal development in adolescents, and is finally responsible for accelerated bone 
loss in adulthood in both women and men, leading to the development of osteoporosis. Importantly, 
there is also evidence from epidemiological studies, clinical intervention trials as well as from studies 
with animal models of human diseases that a compromised vitamin D status and inadequate calcium 
nutrition are predisposing conditions for a great number of other diseases, including various types of 
cancer, chronic infectious, inflammatory and autoimmune diseases, metabolic disorders, as well as 
hypertension and cardiovascular diseases (Table 1; for details, [1-3]). 
 
2. Why a Low Vitamin D Status and a Nutritional Calcium Deficit are Risk Factors for many 
Chronic Diseases 
 
Vitamin D comes from two sources in humans, it could either be synthesized in form of vitamin D3 
(cholecalciferol) under the influence of solar UV-B radiation in the epidermis, or be absorbed from the 
diet or from supplements and food additives, which in some countries may contain vitamin D2 
(ergocalciferol). In any form, vitamin D is transferred to the liver, where it is metabolized to 25-
hydroxyvitamin D (25-(OH)D). The term 25-(OH)D is used to denote the sum of 25-(OH)D3 and 25-
(OH)D2. Thus, the plasma level of this metabolite reflects the sum of vitamin D from endogenous 
synthesis and from dietary intake, and is therefore a reliable indicator of an individual’s vitamin D 
status. 
Conversion of 25-(OH)D3 to the biologically most active metabolite, 1,25-dihydroxyvitamin D3 
(1,25-(OH)2D3), is catalyzed by the CYP27B1-encoded enzyme, 25-(OH)D-1-hydroxylase, and takes 
place predominantly in the kidney, but also at many extra-renal sites  [4] (see Figure 1): Examples are 
normal and neoplastic epithelial cells of the skin [5], of the gastrointestinal tract  [6,7] and of female 
and male reproductive organs  [8-10] as well as osteoblasts and osteoclasts  [11,12] and cells of the 
vascular  [13], the central nervous  [14] and the immune system [15,16]. 
1,25-(OH)2D3 bound to the nuclear high-affinity vitamin D receptor (VDR) functions as a trans-
activating regulator of gene expression. Circulating 1,25-(OH)2D3, which is produced by up to 90% in 
the kidney, plays a key role in systemic calcium and phosphate homeostasis by regulating ion fluxes in 
its classical target organs, i.e., small intestine, kidney and bone. 1,25-(OH)2D3 is also an important 
local regulator of cellular proliferation, differentiation and function in many organs and cell systems 
that express the 25-(OH)D-1-hydroxylase  [4] (Figure 1). The extent of intracellular synthesis of 
1,25-(OH)2D3 at extra-renal sites depends largely on ambient 25-(OH)D3 levels and is not associated 
with circulating 1,25-(OH)2D3 concentrations (e.g.,  [17]). Therefore, at low serum levels of 25-
(OH)D, 25-(OH)D-1-hydroxylase activity may not be sufficient to maintain tissue concentrations of 
1,25-(OH)2D3 necessary for efficient autocrine/paracrine regulation of cellular growth and function. 
This explains why many chronic diseases, as listed in Table 1, show significant negative associations 
with serum 25-(OH)D  [1,3,18]. Importantly, low serum 25-(OH)D has been shown to be a reliable 
predictor of all-cause mortality  [19]. 
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Table 1. Rating of evidence for association of vitamin D and/or calcium insufficiency with 
frequent chronic diseases (for details,  [1,3]). 
Vitamin D insufficiency Nutritional Calcium deficit 
A. Convincing evidence from multiple epidemiological (prospective, cross-sectional,  
retrospective) large cohort studies, interventional trials and experimental studies 
Osteoporosis  
Cancer (colorectal, breast) 
Osteoporosis  
Cancer (colorectal, breast) 
B. Good evidence from >3 observational studies and/or interventional trials 
Cancer (renal , prostate, endometrial, ovarian, 
esophageal, gastric, pancreatic, bladder) 
Hodgkin’s and non-Hodgkin’s lymphoma 
Cardiovascular disease 
 
Neuromuscular dysfunctions 
Diabetes mellitus Type I      
Tuberculosis  
Gingivitis  
Periodontal disease, tooth loss 
Cancer (renal) 
 
 
Cardiovascular disease 
Hypertension 
Neuromuscular dysfunctions  
 
 
 
Periodontal disease, tooth loss 
C. Emerging evidence from observational studies 
Hypertension 
Metabolic Syndrome  
Diabetes mellitus Type II 
 
Metabolic Syndrome  
Diabetes mellitus Type II 
D. Evidence mainly from studies with animal models of the respective human disease 
Inflammatory bowel disease 
Multiple Sclerosis 
Inflammatory bowel disease 
Multiple Sclerosis 
 
Figure 1. Synthesis, absorption and metabolism of vitamin D. 
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There is evidence from many human and animal studies for a significant inverse relationship 
between dietary calcium and risk of multiple chronic diseases  [1]. This is difficult to understand 
because the effect of even large variations in calcium intake levels on extracellular calcium 
concentrations [Ca2+]o is attenuated by the systemic actions of calcium-regulating hormones allowing 
physiological variations in [Ca2+]o to occur only within a narrow range. However, many types of cells 
express a calcium-sensing receptor (CaR), which senses even minute changes in [Ca2+]o and thus  
allows Ca2+ to function as a “first messenger” for various cellular responses  [20]. An important 
feature of the CaR is the high cooperativity between multiple Ca2+-binding sites in its extracellular 
domain. This results in amplification of signals from extracellular Ca2+, which, by cell-specific 
coupling to stimulatory and inhibitory G proteins, are transduced into various intracellular signalling 
pathways. Expression of a functioning CaR thus allows cell-specific reactions to physiological changes 
in [Ca2+]o. The CaR not only controls PTH secretion from parathyroid gland cells but plays key roles 
in normal cartilage and bone formation  [21-23], as well as in limitation of cellular growth of normal 
and neoplastic cells [2,24]. Conversely, low dietary calcium causes hyperparathyroidism by 
impairment of CaR activity and, by the same token, can be linked to the development of not only 
osteoporosis and various malignancies, but possibly other calcium-insufficiency-related chronic 
diseases (Table 1) (for details,  [1,3]; see also Figure 2). 
 
Figure 2. Tissue-specific consequences of low vitamin D and calcium status on cellular 
proliferation and differentiation. ECF, extracellular fluid. 
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Relevant for our understanding how vitamin D and calcium status interact in the pathogenesis of 
chronic diseases, is the observation that most cell types jointly express the 25-(OH)D-1-hydroxylase 
and the CaR. Therefore, cell-specific cooperative signalling from 1,25-(OH)2D3/VDR and CaR, which 
is necessary to maintain normal cell functions (as detailed in  [1,3]), is impaired under conditions of 
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vitamin D and calcium insufficiency (Figure 2). This has been shown particularly for osteoporosis and 
many malignancies, particularly colorectal and breast cancer (as detailed in the following). Low serum 
25-(OH)D and inadequate calcium intake reportedly are associated with cardiovascular risk factors 
such as hypertension  [25-27], obesity [28-30], metabolic syndrome and diabetes mellitus type 
II  [31,32]. Vitamin D and calcium insufficiencies have also been correlated with incident 
cardiovascular symptoms, including angina, coronary insufficiency, myocardial infarction, transient 
ischemic attack, and stroke  [33], as well as with greater mortality from chronic cardiovascular 
disease  [19,34,35]. 
 
3. Vitamin D Insufficiency: A World-Wide Phenomenon 
 
3.1. Definition of Vitamin D Insufficiency 
 
The vitamin D status of an individual is a composite of UV-B mediated synthesis of vitamin D3 in 
the epidermis and of intake and absorption from the gut. Outright vitamin D deficiency is indicated by 
plasma 25-(OH)D levels below 10-15 nM  [36]. In this situation, 1,25-(OH)2D production in the 
kidney is severely limited because of substrate depletion, causing a decrease in intestinal calcium 
absorption with rickets or osteomalacia as a consequence. At 25-(OH)D serum concentrations above 
15 nM, the kidney produces enough 1,25-(OH)2D3 to maintain systemic mineral ion homeostasis  [37], 
but availability of 25-(OH)D for intracellular production of 1,25-(OH)2D3 at extra-renal sites may be 
insufficient for autocrine/paracrine control of cellular functions  [1]. The definition of vitamin D 
insufficiency is still a matter of debate. At one time, a serum 25-(OH)D concentration of ~30 nM was 
thought to be the delimitation between vitamin D insufficiency and adequate vitamin D supply  [38]. 
Now there is growing agreement that serum 25(OH)D should be at least 50 nM  [39] (see also Tables 
2-4). Even higher cut-offs, e.g. 60-100 nM, are supported by studies on optimal health outcomes  [40].  
 
3.2. Epidemiology of Vitamin D Insufficiency 
 
Considering reasons for vitamin D insufficiency, one has to take into account that cutaneous UV-B-
mediated production of vitamin D3 is affected by many factors, such as time of the day, season of the 
year, latitude, altitude, skin pigmentation or use of sunscreens. Also aging can markedly reduce the 
capacity of the skin to produce vitamin D3  [41]. Geographical differences in vitamin D status result 
from varying contributions to the vitamin D supply from exposure to solar UV-B but also from intake 
of dietary and supplemental vitamin D  [42,43].  Table 2 lists the results of the available nationally 
representative studies on prevalence of vitamin D insufficiency in the normal adult population in 
Europe, North America, East Asia and in the South Pacific area.  
In Europe, 7-27% of the adult population have a serum 25-(OH)D concentration below 25-30 
nM  [26,38,44-47]. In South-East Asia and in Australia, incidence of vitamin D insufficiency varies 
between 8-17%  [48-50]. A relatively low value of  5% has been reported for the USA  [51]. However, 
if 50 nM 25-(OH)D is considered the upper reference limit, on the average one-half of the adult 
population in Europe [26,38,44-47], Western Canada  [52], Australia  [53,54] and New Zealand  [55] 
presents with vitamin D insufficiency, whereas only one-third is afflicted in the USA  [51] (Table 2). 
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Table 2. Prevalence of vitamin D insufficiency in healthy adults in selected countries. 
Country 
Population 
segment 
% Vitamin D insufficiency 
Study 
with upper reference limit at
Age (yr) Gender 25–30 nM 50 nM 
Europe 
Austria 19–79 M + F 26 60 Kudlacek et al. [44] 
Denmark 45–58 F 7 40 Brot et al. [45] 
Finland 31–43 M + F 27  Lamberg–A. et al.[47] 
France 35–65 M + F 14  Chapuy et al. [38] 
Germany 18–79 M + F  58 Hintzpeter et al. [26] 
UK 45 M + F 16 47 Hypponen & Power [46] 
North America 
Canada (Alberta) 27–89 M + F  61 Rucker et al. [52] 
USA 20–49 M + F 5 32 Looker et al. [51] 
South–East Asia 
Bangladesh 16–40 F 12 – 17  Islam et al. [48] 
Japan 30–66 F 10  Nakamura et al. [50] 
South Pacific 
Australia (Queensland) 17–65 M + F 8 a) 23 McGrath et al. [49] 
Australia (Queensland) <60 M + F  40 Van der Mei et al. [54] 
Australia (Victoria) 20–92 F 11 43 Pasco et al. [53] 
Australia (Geelong) <60 F  37 Van der Mei et al. [54] 
Australia (Tasmania)  <60 M + F  67 Van der Mei et al. [54] 
New Zealand 15–65+ M + F  48 Rockell et al. [55] 
a) Serum 25-(OH)-D <38 nM 
 
It must be noted that  the proportion of the general population with serum 25-(OH)D below the 
desirable level of 70–80 nM  [40,56] is 73% in the USA  [51], 84–87% in Europe and in the South 
Pacific area   [44,46,55] and up to 97% in Canada  [52]. 
 
3.3. Vitamin D Insufficiency in Different Population Segments 
 
Elderly people: It has been known for decades that vitamin D insufficiency is common in people, 
who are immobilized because of chronic diseases or are housebound due to old age. However, recent 
nationally representative data show that vitamin D insufficiency is present in a substantial portion of 
old age ambulant people worldwide (Table 3): For example,  the European SENECA Study on diet and 
health of elderly people from 19 towns in 12 European countries revealed that overall 36% of men and 
47% of women had serum 25-(OH)D concentrations below 30 nM  [57]. In the Netherlands, 50% of 
people aged 65 years and older had serum levels of 25-(OH)D below 50 nM  [58]. Similar values were 
reported for elderly women in Belgium  [59]. According to the OPTIFORD Study  [60], 50-92 % of 
elderly women in Denmark, Finland, Ireland and Poland had wintertime 25-(OH)D concentrations 
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lower than 50 nM. On the average, prevalence of vitamin D insufficiency in elderly people in North 
America  [51,61], Australia  [62], New Zealand  [55] and Japan  [63] seems to be lower than in Europe 
(Table 3). 
 
Table 3. Prevalence of vitamin D insufficiency in elderly people. 
Country 
Population segment
% Vitamin D insufficiency  
Study 
with upper reference limit of 
serum 25-(OH)D at 
Age (yr) Gender 25–30 nM 50 nM 
Europe 
Belgium 76.5 ± 7.5 F 16 43 Neuprez et al. [59] 
Denmark 70–75 F 17 55 Andersen et al. [60] 
Finland 70–75 F 10 57 Andersen et al. [60] 
Ireland 70–75 F 14 60 Andersen et al. [60] 
Italy 75–80 F 92  v. d. Wielen et al. [57] 
Netherlands 65+ M + F 13 52 Wicherts et al. [58] 
Poland 70–75 F 25 92 Andersen et al. [60] 
Switzerland 75–80 M 12  v. d. Wielen et al. [57] 
North America 
USA 55+ F 4 14 Lappe et al. [61] 
USA 50–70+ M 10 27 Looker et al. [51] 
East Asia 
Japan 46–82 F 5 28 Nakamura et al. [63] 
South Pacific 
Australia 75+ F 22  Flicker et al. [62] 
New Zealand 65+ M  41 Rockell et al. [55] 
 
Children, adolescents and young adults: In some European countries such as Denmark, Finland, 
Ireland and Poland  [60], 37% of 12-year old girls had 25-(OH)D concentrations lower than 25 nM 
(Table 4). By using a broader definition, i.e., <50 nM, 92% had to be considered vitamin D-
insufficient. Comparative values are much lower in Germany  [64], but considerably higher in 
France  [65].  
In the USA, the proportion of male and female adolescents between 12-19 years, who had 25-
(OH)D values below 50 nM, ranged from 24 to 31%, respectively  [51]. Incidence of vitamin D 
insufficiency in younger women is low in Canada  [66], compared to Indonesia, Malaysia  [67] or 
Japan  [50]. Alarmingly high rates were found in older girls and young women at child-bearing age in 
India  [68] and China  [69,70] (Table 4). 
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Table 4. Prevalence of vitamin D insufficiency in children, adolescents and young adults. 
  % Vitamin D insufficiency        
Country 
Population 
segment 
with upper reference limit 
    of serum 25–(OH)D at  
Age (yrs) Gender 25–30  nM 50 nM Study 
Europe 
Germany 3–17 M  18 62 Hintzpeter et al.[64] 
Germany 3–17 F 18 65 Hintzpeter et al. [64] 
France 13–16 M  78  Guillemant et al. [65] 
Denmark 12–13 F 51 93 Andersen et al. [60] 
Finland 12–13 F 37 97 Andersen et al. [60] 
Ireland 12–13 F 26 89 Andersen et al. [60] 
Poland 12–13 F 33 87 Andersen et al. [60] 
North America 
USA 12–19 M  10 24 Looker et al. [51] 
USA 12–19 F 16 31 Looker et al. [51] 
Canada 18–35 F  >15 Vieth et al. [66] 
South–East Asia 
India (Delhi) 6 – 18 F  91 Puri et al. [68] 
China 20–35 F 18–40 >90 Woo et al. [70] 
China 15 F 31 89 Foo et al. [69] 
Indonesia  18–40 F  63 Green et al.  [67] 
Malaysia  18–40 F  60 Green et al.  [67] 
Japan 19–30 F 42  Nakamura et al. [50] 
South Pacific 
New Zealand 15–18 M   55 Rockell et al. [55] 
New Zealand 19–24 F  52 Rockell et al. [55] 
 
Pregnant women and neonates: In Europe and in the USA, a poor vitamin D status is observed with 
increasing frequency in pregnant women  [71] and consequently in their neonates  causing a high risk 
of not only rickets, but also non-skeletal diseases in later life, e.g. type 1 diabetes  [72].  
Obesity deserves a special note as a condition frequently associated with vitamin D and calcium 
insufficiency. A number of earlier studies have well documented a high prevalence of vitamin D 
insufficiency in morbidly obese women. Now evidence is emerging that in otherwise healthy women 
and men, body fat mass is frequently inversely associated with vitamin D insufficiency  [29,73]. 
Sequestration of vitamin D in the subcutaneous fat, which alters its release into the circulation, could 
be one by which obesity could contribute to vitamin D insufficiency  [74].  
Ethnic groups: The immigrant population is at high risk for vitamin D insufficiency in many  
European countries such as Denmark, Norway and Great Britain  [75-77]. In Germany, the proportion 
of vitamin D inadequacy in children and adolescents, aged 2-17 years, is higher in immigrant than in 
non-immigrant girls and boys at any time. Notably, after termination of vitamin D supplementation for 
prophylaxis of rickets between the age of 1-2 years, serum 25-(OH)-D levels fell rapidly below 50 nM 
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in both groups  [64]. In the USA, prevalence of vitamin D insufficiency in Mexican American and 
Non-Hispanic black people is higher than in Non-Hispanic White individuals  [51]. Analogous skin 
pigmentation and degree of vitamin D inadequacy has been reported for three ethnic groups in New 
Zealand, i.e., Pacific people, Maori and people of European origin  [55]. In Australia, dark-skinned and 
“veiled” women, particularly when pregnant, belong to the group with the highest risk for vitamin D 
insufficiency  [78].   
 
4. Inadequate Calcium Intake: A World-Wide Problem 
 
4.1. Recommended Calcium Intake Levels 
 
Different intake levels for calcium are recommended by FAO/WHO experts for infants, children 
and adults  [79] to assure optimal whole body calcium retention and consequently adequate 
development and maintenance of bone mass and mineral density. For children and adolescents 
between 10–18 years of age, consumption of 1,300 mg per day is recommended, while 1,000 mg per 
day apply for men between 25–50 years of age and also for women in the same age group, except 
when higher intake is necessary during pregnancy or after menopause. Recommended calcium 
allowance per day for males over 65 years and postmenopausal women is 1,300 mg  [79].  
 
Table 5. Nutritional calcium deficit in selected countries. 
Country 
Age 
(yrs) 
DRI a) 
(mg/day) 
Calcium intake (mg/day) 
Study 
 Gender 
 M F 
Europe 
Austria 19–79 >1,000 561 (±290) b) 576 (±309) b) Kudlacek et al. [44] 
 <40   1,000 604 (±345) b) 560 (±299) b) Kudlacek et al. [44] 
 40–60 >1,000 590 (±318 ) b) 561 (±287) b) Kudlacek et al. [44] 
Germany 18–79 >1,000 1,181 (902–1,535) 1,082 (849–1,379) Hintzpeter et al. [26] 
 Adults   1,000 619 (213–1,025) 705 (313–1,094) Anke [80] 
 40–64 >1,000 774 (334–1,330) c) 707 (287–1,225) c) Schulze et al. [81] 
UK f) 45–55   1,000 1,133 (950–1,316) 1,063 (931–1,195) Vyas et al. [82] 
North America 
USA 19–50   1,000 812 (788–837) 626 (596–659) Ma et al. [83] 
South–East Asia 
Bangladesh 16 – 40   1,000  180 e) Islam et al. [86] 
Indonesia 18–40   1,000  270 (239–302) d) Green et al.  [67] 
Malaysia 18–40   1,000  386 (353–420) d) Green et al.  [67] 
South Pacific 
Australia 20–94 >1,000  643 (±340) b) Pasco et al. [84] 
   M + F  
New Zealand 40–64 >1,000 794 (8–1,580) e) Metcalf  et al. [85]  
a) Daily Recommended Intake by FAO/WHO  [79]; b) mean (±SD); c) median (90% CI); d) median (95% CI); 
e) mean (range); f) white, urban population 
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4.2. Epidemiology of Calcium Intake  
 
Findings listed in Table 5 indicate that in Europe daily calcium intake from nutrient sources is 
consistently low. For example, 84% of the adult population in Austria fail to meet recommended 
intake levels  [44]. The situation is apparently better in Germany  [80,81], with one study reporting 
daily calcium intake even at recommended levels  [26]. This seems to be also the case in Great 
Britain  [82].  
In contrast, 40% of the population does not meet adequacy in the USA  [83]. Similar values 
probably pertain for Australia  [84] and New Zealand  [85]. Special consideration must be given to the 
nutritional calcium deficit in South-East Asian countries such as Indonesia, Malaysia  [67] and 
Bangladesh  [86]: The situation is particularly alarming in Bangladesh, where 47% of premenopausal 
women in the higher socio-economic brackets failed to meet a daily allowance of 400–500 mg 
calcium, and 63% of women of low socio-economic standing had calcium intake even lower than 200 
mg/day  [86]. 
 
Table 6. Nutritional calcium deficit in elderly people. 
Country 
 Calcium intake (mg/day) 
Study 
Age 
(yrs) 
DRI 
(mg/d)a) M F 
Europe 
Austria >60 1,300 503 (±221) b) 569 (±287) b) Kudlacek et al. [44] 
Belgium 75–80 1,300 748 (324–1,166) c) 676 (287–1,101) c)  Amorim Cruz et al. [88]  
Denmark 70–75 1,300  544 (127–1,812)d) Andersen et al. [60] 
Finland 70–75 1,300  975 (404–2,313) d) Andersen et al. [60] 
France 75–80 1,300 620 (402–1,010) c) 635 (428–944) c) Amorim Cruz et al. [88] 
Ireland 70–75 1,300  824 (339–1,669) d) Andersen et al. [60] 
Netherlands 75–80 1,300 1,036 (725–1,447) c) 1,010(612–1,616) c) Amorim Cruz et al. [88] 
Poland 70–75 1,300  325 (86–851) d) Andersen et al. [60] 
North America 
USA >55 1,300  611 (381–892) c) Lappe et al. [61] 
South–East Asia 
Japan 65–75 1,300  527 (±195) b) Nakamura et al. [89] 
a) Daily Recommended Intake by FAO/WHO  [79]; b) mean (± SD; c) mean (range); d) median 
(97.5% CI) 
 
4.3. Population Segments with Low Habitual Calcium Intake 
Chronically ill people: A chronically negative calcium balance due to malabsorption develops, for 
example, in the many individuals suffering worldwide from lactose intolerance or from inflammatory 
bowel disease (Crohn’s disease, ulcerative colitis). In addition, calcium malabsorption must be 
reckoned with in all cases of vitamin D insufficiency resulting from intestinal, hepatic, renal or 
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endocrine disorders as well as in the group of bariatric surgery patients who increase in numbers as a 
result of the obesity epidemic in the affluent parts of the world. 
Individuals with reduced physical activity: It must be noted that immobilization even for a short 
period, e.g. 1-2 weeks of bed rest leads to mobilization of calcium from bone and consequently to net 
calcium loss  [87]. Therefore not only patients in geriatric, psychiatric or neurological care, but also 
healthy individuals with low habitual physical activity have an increased risk of calcium insufficiency. 
Elderly people: The data collated in Table 6 confirm the long-standing assumption that particularly 
the elderly ingest significantly less calcium in their diet than the recommended amount, which is 
currently considered 1,300 mg per day for this age group  [79]. In the European SENECA Study  [88], 
the overall mean calcium intake by elderly people was  894 mg per day, with variations from 600-
1,100 mg between different study sites. In the OPTIFORD Study, the median calcium intake among 
elderly women was 632 mg per day, being lowest in Poland (325 mg) and highest in  Finland (925 
mg)  [60]. In the USA, the mean intake of calcium in women after age 55 is only ~600 mg/day  [61]. 
Daily consumption of ~500 mg by elderly Japanese women  [89] is far below a recommended level of 
1,200 mg, although daily calcium requirements of East Asian populations may be lower for ethnic 
reasons  [79] . 
Children, adolescents and young adults: In the European OPTIFORD study the median daily 
calcium intake of girls at a mean age of ~13 years was 823 mg, ranging from 524 mg in Poland to 
1,092 mg in Finland  [60] (Table 7). Data from the USA indicate that after the age of 10, calcium 
malnutrition is a common phenomenon. For example, average daily calcium intake in a group of young 
adolescents (12.7 ± 1.0 yr of age) was found to be 906 mg  [90]. Grossly inadequate calcium intake 
was observed also in young adults in Canada  [91]. Average daily calcium intake by schoolgirls in 
India between 400–500 mg  [68], though corresponding to recommended daily allowances for Indians, 
nevertheless is far below current FAO/WHO recommendations of 1,000–1,300 mg/day  [79]. 
Ethnic groups: It has to be borne in mind that not only vitamin D deficiency but also a nutritional 
calcium deficit is an important cause of rickets  [92]. So-called calcium deficiency rickets are prevalent 
in Middle Eastern and many sub-tropical and tropical countries, such as Nigeria, Ethiopia, South 
Africa, India and Bangladesh, despite the fact that such countries have ample sunlight  [93-95]. Under 
this condition, the disease is attributable to low dietary calcium intake from mainly cereal-based diets. 
 
5. Strategies for disease prevention 
 
Studies on the vitamin D intake in different parts of the world cannot be directly compared because 
results may be confounded to some extent by differences in life style and clothing habits, consumption 
of traditional foods or supplement intake. Exact determination of the extent of calcium malnutrition is 
also difficult, because different methods are used for evaluation of daily calcium intake from nutrient 
sources and, in addition, for ethnic, dietary and geographical reasons different recommendations apply 
for different parts of the world  [79]. However, combined evidence from all the studies that are 
included in the present survey clearly indicates that vitamin D insufficiency and calcium malnutrition 
are common in both genders worldwide, not only in elderly people as previously believed but also in 
younger adults. Importantly, the highest rates of insufficiencies are found in children and adolescents 
as well as in women of child bearing age. 
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Table 7. Nutritional calcium deficit in children, adolescents and young adults. 
a) Daily Recommended Intake by FAO/WHO  [79]; b) median (97.5% CI); c) mean (range),  
d) mean (±SD) 
 
5.1. Need to Increase Combined Intakes to Daily 800 IU Vitamin D and 1,200 mg Calcium 
 
Vitamin D: A recent survey on world-wide vitamin D intake  [96] clearly indicates that in many 
countries vitamin D supply from nutrient sources is too low to sustain mean 25-(OH)D levels in the 
general population between 40-100 nM, which are considered sufficiently high to achieve a better 
health outcome  [97]. Cashman et al.  [98] calculated that in 20-40 yr old adults, depending on the 
extent of sun exposure in summer, daily intakes of vitamin D between 300 and 1,600 IU are required 
to maintain an adequate vitamin D status in wintertime. Notably, Nelson et al.  [56] reported that daily 
doses of 800 IU vitamin D3 were sufficient to sustain “optimal” 25-(OH)D serum concentrations 
(≥75nM) in 80% of a group of pre-menopausal women. With approximately the same daily dose of 
vitamin D3, serum 25-(OH)D levels could be maintained at 50 nM in 97.5% of a group of  elderly 
people in the absence of sufficient sun exposure  [99]. The beneficial effects of 800 IU supplemental 
vitamin D for various health outcomes are well documented. Daily intake of 700-800 IU vitamin D3 
maintains normal bone turnover in healthy men at wintertime  [100], and reduces the risk for colorectal 
or breast cancer by 50%  [101,102].  
Calcium: The suggestion to raise daily consumption of calcium to an average of 1,200 mg per day 
is based not only on physiological considerations [103] but can be deduced also from considerations of 
optimal health outcomes: For example, daily doses of 1,200 mg calcium effectively prevent 
osteoporotic bone loss and fractures in people aged 50 years or older [104], and cause a 40-50% risk 
reduction of colorectal cancer in men and of breast cancer in premenopausal women  [105,106]. 
 
 
 
Country 
          Calcium intake (mg/day) 
Study 
                       Gender 
Age 
(yr) 
DRI a) 
(mg/day) M + F F 
Europe 
Denmark 12.6 1,300  831 (260–2,475) b) Andersen et al. [60] 
Finland 12.6 1,300  1,092 (546–2,452) b) Andersen et al. [60] 
Ireland 12.6 1,300  728 (54–2,259)  b) Andersen et al. [60] 
Poland 12.6 1,300  524 (117–1,580)  b) Andersen et al. [60] 
North America 
USA 12.7 1,300 906 (417–1,616) c)  Abrams et al. [90] 
Canada 18–35 1,000  562  (0–2,630) c) Rubin et al. [91] 
South-East Asia 
India (Delhi) 6–18 700-1,300   575 (±219) d) Puri et al. [68] 
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5.2. Rationale for Advocating Combined Intake of Vitamin D and Calcium  
 
Simultaneous correction of nutritional vitamin D and calcium deficits for prevention or 
amelioration of many chronic diseases is necessary for two reasons: First, dietary intakes of vitamin D 
and calcium are strongly associated  [107] and therefore vitamin D insufficiency is frequently 
associated with low calcium intake  [1,44]. Second, because vitamin D and calcium interact positively 
in modulation of cellular proliferation, differentiation and function, as detailed before  [3,18], it can be 
expected that an adequate vitamin D status is required to achieve the nutritional benefits of calcium  
and vice versa.  
Osteoporosis:  Combined supplementation with daily 800 IU vitamin D and 1,200 mg calcium is 
the essential basis for pharmacological prevention and treatment of osteoporosis. From a meta-analysis 
of 10 randomized controlled trials of oral vitamin D with or without calcium supplementation vs 
placebo/no treatment on the risk of hip fracture in elderly people, Boonen et al.  [108] concluded that 
oral vitamin D appears to reduce the risk of hip fractures only when calcium supplementation is added. 
Cancer: Lappe et al. [109] reported evidence from a randomized placebo-controlled trial that in 
post-menopausal women combined high-dose calcium and vitamin D3 supplementation, i.e., 1,400–
1,500 mg calcium plus 1,100 IU vitamin D3, reduced the cumulative risk of cancer of the breast, lung, 
colon, uterus, lymphoid and myeloid system to 0.232 after four years of trial. Cho et al.  [110] 
concluded from an analysis of pooled primary data from 10 cohort studies with a follow-up of more 
than half a million individuals for 6–16 years, that optimal risk reduction for colorectal cancer 
necessitates high intake levels of both vitamin D and calcium. This notion was shown to be valid not 
only for Western but also for Asian populations  [111]. In pre-menopausal women, Bérubé et al.  [112] 
found highly significant inverse relations between total intakes of vitamin D and calcium and breast 
density, which is a surrogate marker for breast cancer risk. It is noteworthy, that higher intake of one 
nutrient was related to lower breast density only in the presence of higher intake of the other nutrient.  
 
6. What can be Done? 
 
Simultaneous supplementation of vitamin D and calcium represents a safe and inexpensive strategy 
for prevention of osteoporosis, colorectal and breast cancer and possibly of many other chronic 
diseases (Table 1). It must be emphasized that daily consumption of 800 IU vitamin D and 1,200 mg 
calcium is well below the currently accepted tolerable upper intake levels of 2,000 IU (=50 g) 
vitamin D3 and 3,000 mg calcium  [79].  
 
6.1. Supplementation by Fixed Vitamin D/Calcium Combination Tablets 
 
Osteoporotic fractures can be effectively prevented at relatively low cost by combined 
supplementation with 1,200 mg/d calcium and 800 IU/d vitamin D3. However, a significant effect of 
vitamin D/calcium treatment is only seen in cohorts with at least 80% compliance  [104]. Low 
compliance and lack of adherence seen with any long-term medication certainly will limit the 
usefulness of combined vitamin D and calcium supplementation for correction of respective 
insufficiencies in the general population. Therefore, combined vitamin D and calcium supplementation 
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should be promoted specifically for disease prevention in high risk groups, i.e., individuals, who 
otherwise are unable to attain a normal vitamin D and calcium status due to specific living conditions 
(immobilization, physical incapacitation, advanced age, chronic diseases), traditional or personal 
nutritional habits, preferred lifestyle (lack of physical activity, indoor dwelling) etc.  
 
6.2. Vitamin D and Calcium Enrichment in Single Foodstuffs 
 
Fortified foods are an important source of vitamin D for those who consume them  [113]. In a 
recent survey on the efficacy of food fortification on serum 25-(OH)D concentrations  [114], dose-
effect relations for vitamin D from food sources were found  equivalent to those reported for vitamin D 
supplements. Vitamin D-fortified milk has been found to be a safe, effective and acceptable method of 
administering vitamin D, particularly to the elderly, community-based population. Orange juice 
fortified with vitamin D2 (1,000 IU/240 ml) was tested for its suitability to serve as an alternative for 
vitamin D-fortified milk. Fortification with vitamin D3 of wheat and rye bread is technically easy, and 
stability and bioavailability of vitamin D is good  [115]. Consumption of bread fortified with 5,000 IU 
vitamin D3 and 320 mg calcium per daily serving for 12 months improved the vitamin D status of sun-
deprived nursing home residents. Together with suppression of secondary hyperparathyroidism this 
apparently caused a significant increase in bone mineral density at the lumbar spine and the hip  [116]. 
Calcium fortification is in use all over the world: Staples and food stuffs that are enriched with 
calcium include flour, cereals, milk, orange juice, mineral waters, soymilk etc.  [117]. Calcium- and 
vitamin D-fortified milk, when providing 800 IU vitamin D and 1,000 mg calcium per day, has a 
significant positive effect on bone mass and  strength in older men  [118,119]. 
It is apparent that fortification of traditional and widely consumed foodstuffs (milk and milk 
products, bread, orange juice etc.) will guarantee a minimum additional supply of vitamin D and 
calcium.  
 
6.3. Vitamin D and Calcium Addition to Cereal Grain Products 
 
At present, cereal grain products, such as flour, corn meal, noodles and the like, are enriched with 
vitamin D and calcium in some countries in Europe and in the USA. Newmark et al.  [117] 
summarized the rationale, data, efficacy, safety, cost and practicality of the addition of both calcium 
and vitamin D to cereal grain products to reduce the risk of osteoporosis and colon cancer.  The 
authors estimate that, if cereal grain products were uniformly enriched with 90 IU/100g vitamin D, 
average daily intake of vitamin D could increase by up to 200 IU vitamin D. Enrichment of cereal 
grain products with 1,200-1,800 mg/kg calcium could raise dietary intake by about 200-400 mg/day. A 
conservative estimate suggests that through these measures at least a 20% reduction of the rate of 
osteoporotic fractures  and of colorectal  incidence can be achieved  [117].  
Enrichment of cereal grain products with vitamin D and calcium at indicated levels would be 
possible within current legal regulations in the USA  [117]. It also conforms to legislation introduced 
in the European Union as of 2007. However, some important member states such as Germany have not 
yet changed their national law accordingly.   
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In summary, enrichment with vitamin D and calcium of cereal grain products is an effective and 
safe measure at very low cost to broaden the range of commonly consumed foods as dietary sources of 
vitamin D and calcium. This will guarantee at least some modest improvement in both vitamin D and 
calcium nutrition at the same time without necessitating a change in traditional eating habits. To fulfill 
individual needs for vitamin D and calcium however, additional consumption of particularly vitamin 
D- and calcium-rich food and food products or even supplement use is certainly indicated.  
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